• Shardlow A, et al.. Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3. BMJ Open. 2017; http://dx.doi.org/10.1136/bmjopen-2017-016528].

    • Crossref
    • Search Google Scholar
    • Export Citation

FGF23 Doesn’t Predict Outcomes in Patients with Low-Risk Stage 3 CKD, Study Finds

Restricted access
Save